Clinical trial · Interventional
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer
NCT02324127CI-TRIAL-00016458unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hsp90 | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- liver cancer
- description
- Detect plasma Hsp90α concentration of liver cancer patients
- interventionNames
- Device: hsp90
Primary outcomes (1)
- measure
- Hsp90α Concentration of plasma
- timeFrame
- 4 months
- description
- Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Liver cancer patients * Healthy volunteers, * Benign liver diseases patients Exclusion Criteria: * Patients who Previously accepted radiotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.